Protease nexin I (PNI) is a member of the family of serine protease inhibitors (serpins) that have been shown to promote neurite outgrowth in vitro from different neuronal cell types. These include neuroblastoma cells, hippocampal neurons, and sympathetic neurons. Free PNI protein is markedly decreased in various anatomical brain regions, including hippocampus, of patients with Alzheimer disease. Here, we report that PNI rescued spinal motoneurons during the period of naturally occurring (programmed) cell death in the chicken in a dose-dependent fashion. Furthermore, PNI prevented axotomy-induced spinal motoneuron death in the neonatal mouse. The survival effect of PNI on motoneurons during the period of programmed cell death was not associated with increased intramuscular nerve branching.
death in the chicken in a dose-dependent fashion. Furthermore, PNI prevented axotomy-induced spinal motoneuron death in the neonatal mouse. The survival effect of PNI on motoneurons during the period of programmed cell death was not associated with increased intramuscular nerve branching.
PNI also significantly increased the nuclear size of motoneurons during the period of programmed cell death and prevented axotomy-induced atrophy of surviving motoneurons. These results are consistent with the possible role of PNI as a neurotrophic agent. They also support the idea that serine proteases or, more precisely, the balance of proteases and serpins may be involved in regulating the fate of neuronal cells during development.
During normal development, '50% of postmitotic lumbosacral motoneurons undergo naturally occurring (programmed) cell death during a period when these cells are forming synaptic connections with their target muscles (1, 2) . Naturally occurring motoneuron death has been described in many vertebrate species, including chicken (2, 3) , mouse (4, 5) , rat (6) , and human (7) embryos or fetuses. For example, programmed motoneuron death occurs between embryonic day (E)6 and E10 in the chicken (2) . This system has been used as a biological model for testing different neurotrophic agents on motoneuron survival in vivo (8, 9) .
Although programmed cell death is completed before birth in mammals, the maintenance of motoneurons continues to be dependent on support from the target for some time after birth. Thus, if transection of motor axons is performed in neonatal mammals and reinnervation is prevented, a large number of motoneurons degenerate and die (10) (11) (12) (13) . Axotomy-induced death of motoneurons has also been extensively used as a model for testing the survival effects of various agents, including neurotrophic and growth factors on motoneurons (14) (15) (16) (17) .
Protease nexin I (PNI) (18) , also known as glia-derived nexin (19) , is a 43-to 47-kDa protein that was first found secreted by cultured fibroblasts (20) but is also produced by glial (glioma and primary) and skeletal muscle (21, 22) cells.
PNI has been shown to promote neurite outgrowth in vitro from different neuronal cell types. These include neuroblastoma cells as well as primary hippocampal and sympathetic neurons (19, 21) . The neurite-promoting activity of PNI in vitro is mediated by inhibition of thrombin, a potent serine protease (21) . PNI (mRNA and protein) is transiently up-regulated in rat sciatic nerve after axotomy, and PNI-producing cells are localized distal to the lesion site (23) . This up-regulation of PNI occurs 2-3 days after a similar up-regulation of prothrombin and thrombin in the distal stump (I. V. Smirnova, J. A. Ma, and B.W.F., unpublished data). Other bona fide neurotrophic agents such as nerve growth factor, brain-derived neurotrophic factor, and insulin-like growth factor I exhibit similar responses to peripheral nerve injury. Free PNI protein is significantly decreased, while endogenous PNI-thrombin complexes are increased, in various anatomical brain regions, including hippocampus, of patients with Alzheimer disease (24) . When considered together with the recent demonstration that PNI can promote the in vitro survival of mixed mouse spinal cord neurons and that PNI is released from glial cells by neuropeptides such as vasoactive intestinal polypeptide (25), these observations suggest that PNI may play a physiological role in neuronal survival, differentiation, and/or axonal regeneration in vivo.
In the present report, we examined whether PNI could promote the survival of spinal motoneurons in two different models-i.e., during the period of programmed cell death in the embryonic chicken and after axotomy in the neonatal mouse. The data show that PNI prevented motoneuron death during development in both of these models. Moreover, PNI increased motoneuron cell sizes during programmed cell death and prevented atrophy of motoneurons after axotomy. (17, 27) . Briefly, only cells with a wellstained cytoplasm and a large nucleus containing one or two distinct nucleoli were counted. Using these rather stringent criteria, we have found previously that <1% of the cells appear on two successive sections and, therefore, only an insignificant number of cells would be counted twice (17, 27) . Two sections were selected from the middle of L4 spinal cord of each animal. From these, the outlines of motoneurons (nuclei and soma), which met the same criteria established for cell counts, were traced with a camera lucida attached to the microscope and digitized with a Summagraphics bit pad interfaced to a computer, and the areas were calculated with SIGMASCAN software (17) . Statistical (Fig. 1) . The survival effect of PNI was dose dependent (Fig. 1) and nuclei were traced with a drawing tube attached to the microscope, and the areas were determined by the SIGMASCAN program (Jandel, Corte Madera, CA). Because motoneurons were densely clustered in embryonic chicken LMC (see Fig. 1 A and B), we were unable to reliably determine chicken motoneuron soma sizes. *, P < 0.0001 vs. control; **, P < 0.001 vs contralateral; ***, P < 0.001 vs. ipsilateral + saline; ****, P < 0.05 vs. ipsilateral + saline (Student's t test).
EXPERIMENTAL PROCEDURES
when compared to E10 controls. One mechanism regulating motoneuron survival may be intramuscular nerve branching to increase the sites of trophic factor uptake (28) . Coupled with the reported neuritepromoting activity of PNI in vitro on various neuronal cell types (21, 31, 32), we examined the patterns of intramuscular nerve branching by the whole-mount technique described previously (28) . Daily treatment of chicken embryos, from E6 to E9, with 5 ,tg of PNI did not alter the number of side branches occurring on intramuscular nerve trunks in the iliotibialis, iliofibularis, or sartorius muscle (Fig. 2) .
Axotomy-Induced Motoneuron Death and Effect of PNI. In neonatal mammals, nerve section results in a massive motoneuron cell loss in the corresponding spinal cord segments (11) . Recently, we have shown that unilateral sciatic nerve section in the mouse on P5 results in a substantial (-45%) loss of motoneurons in the ipsilateral L4 by P12 when compared to the contralateral side (17) . We have also shown that treatment of animals after axotomy with different neurotrophic agents can prevent significant numbers of these cells from injuryinduced death (17) . Therefore, in the present study, we used this experimental paradigm to assess further the rescue effects of PNI on axotomized mouse motoneurons. Remarkably, as we found in avian embryonic programmed motoneuron cell death, PNI significantly rescued mouse motoneurons from axotomy-induced death. As little as 5 ng of PNI prevented the death of >95% (virtually all) of axotomized motoneurons (Fig.  3) and also prevented the atrophy of surviving axotomized motoneurons (Table 1) .
DISCUSSION
This report shows that a member of the serine protease inhibitor (serpin) superfamily (33)-i.e., PNI-can promote the in vivo survival of spinal motoneurons in two different cell death models: during the period of programmed cell death in the chicken and after neonatal axotomy in the mouse. One obvious possible explanation for these results is that PNI may indirectly rescue motoneurons by inhibiting one or more serine proteases involved in the cascade of intracellular events leading to cell death. Consistent with this idea, it has been recently shown that thrombin, a prominent serine protease, induces degeneration and death of neurons and astrocytes in vitro (34) . Furthermore, the deleterious effect of thrombin can be prevented by specific thrombin inhibitors (34) . Similar to other serpins, PNI forms stable complexes with target serine proteases (20, 33) . These include urokinase, tissue plasminogen activator, trypsin, plasmin, thrombin, and kallikrein, all of which are serine proteases that cleave after an arginine residue (18, 33) . Once formed, PNI-protease complexes are recognized by a specific receptor and are rapidly internalized into the cells and degraded (20, 33) . Since certain serine proteases are developmentally regulated in skeletal muscle (26, 35) , it is possible that motoneurons die naturally owing to the proteolytic activity of some musclederived serine proteases. Accordingly, treatment with exogenous PNI might inhibit this proteolytic activity leading to the survival of more motoneurons. The fact that a1-antichymotrypsin, another serpin that inhibits cathepsin G and similar serine proteases, promotes the survival of cultured rat cortical and hippocampal neurons (36, 37) is consistent with this conclusion. Previously, however, treatment with other protease inhibitors failed to rescue rat sympathetic neurons in vitro (38) or embryonic chicken motoneurons in vivo (39) . In fact, in early experiments, glia-derived nexin or PNI failed to promote neuronal survival in culture (40) . One possible explanation for this discrepancy may be the concentration of glia-derived nexin involved (40) (41) and serine proteases have been implicated in apoptosis in the immune system (42) .
Alternatively, PNI may directly regulate the survival and differentiation of motor neurons in vivo and, therefore, may be considered a putative neurotrophic agent. One potential mechanism for this may be the posttranslational production of a trophic PNI fragment from its C terminus after it inhibits thrombin or another target protease. Production of complexes with their cognate proteases, with the release of a variably sized fragment, occurs with most serpins (33 (14, 15, 29, 30) . Since PNI is also synthesized and secreted by skeletal muscle cells in culture (22) and is expressed in adult mouse skeletal muscle, where it is colocalized with acetylcholine receptor clusters at the neuromuscular junctions (22) , these may be physiologically relevant sites for trophic agent uptake by motoneurons. However, it is not yet known whether target muscles express physiologically relevant levels of PNI during the period of programmed cell death or in the neonatal period when mammalian motoneurons are susceptible to axotomy. PNI mRNA is markedly expressed after human myoblast fusion to myotubes (M. Verdiere-Sahuque, M. Akaaboune, S. Lachkar, L. Garcia, G. Barlovatz-Meimon, B.W.F., and D. Hantai, unpublished data), suggesting that PNI might also be expressed in embryonic chicken myofibers. Despite these uncertainties, the evidence for PNI expression and localization in skeletal muscle (22) , together with the reported neurite-promoting (21, 31, 32) and neuronal survival-promoting activities (refs. 25 and 43; this work) of PNI, suggest that this serpin may function as a neurotrophic agent in vivo at specific times during development of the neuromuscular system.
In conclusion, we have shown that PNI, a prominent member of the serpin family with arginine specificity, has survival and growth-promoting effects on spinal cord motoneurons during the period of programmed cell death in the chicken and after axotomy in the mouse. The present data, together with the previously reported effects of PNI on neuronal differentiation (21, 31, 32) and the reduction of active PNI protein in brains of patients with Alzheimer disease (24) , indicate that PNI, and possibly other members of the serpin family known, or yet to be described (44) , may function as important regulators in neuronal development, including survival, differentiation, and axonal regeneration (45 
